Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice
987 is not suitable for use in humans because of excessive inhibition of the hERG antitarget
PubMed Central PMCID: PMC6396177
InChiKey: FSVJFNAIGNNGKK-UHFFFAOYSA-N
Bilobalide is important for producing several of the effects of Gingko biloba extracts
Enrofloxacin Catalog No.:M8968-2 EGFR Tyrosine Kinase Inhibitor (PD153035)Enrofloxacin is a fluoroquinolone antibiotic sold by the Bayer Corporation. It is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration dependent, with susceptible bacteria cell death occurring within 2030 minutes of exposure. Enrofloxacin has demonstrated a significant post antibiotic effect for both Gram negative and Gram positive bacteria and is active in both stationary and growth phases of bacterial replication. Product
US$ 222.50
US$ 118.00
US$ 145.00
US$ 603.50
US$ 195.50
US$ 420.75
US$ 144.00
US$ 194.00